PerkinElmer to Showcase Diagnostics Technologies at Arab Health Congress 2015

PerkinElmer to Showcase Diagnostics Technologies at Arab Health Congress 2015

January 20, 2015 at 12:00 AM EST
WHAT: PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it will display its innovative diagnostics technologies at the 40th annual Arab Health Congress, the second largest healthcare congress and exhibition in the world and the largest in the Middle East.

"We are pleased to share our extensive portfolio of novel diagnostic screening tests with this global audience of medical practitioners, manufacturers, wholesalers, dealers and distributors at Arab Health," said Prahlad Singh, President, Diagnostics, PerkinElmer. "Our breakthrough offerings are critical for prenatal and newborn screening to detect a wide range of disorders, helping to contribute to advancements in human health."
WHEN: January 26-29, 2015
WHERE: Dubai International Convention & Exhibition Centre
AT ARAB HEALTH: PerkinElmer will feature the following diagnostics offerings through HVD Life Sciences, a PerkinElmer authorized, exclusive dealer in the Middle East. For the full product list available in your specific country, please contact HVD. The HVD booth is located in Rashid Hall, stand nr. RA05:

EnLite™ Neonatal TREC Kit: a screening test for Severe Combined Immunodeficiency (SCID). Since 2013, PerkinElmer's SCID screening test has been available for sale in select countries in Europe and the Middle East, introduced under CE marking. PerkinElmer recently received market authorization from the FDA and Health Canada to offer this test commercially in the U.S. and Canada.

CAPILLARYS™ 2 NEONAT FAST: a system that enables fully automated hemoglobin newborn screening from dried blood spot samples by capillary electrophoresis. Its hemoglobin newborn screening assay is designed to separate normal hemoglobins and detect hemoglobin variants. Offered by Sebia®, PerkinElmer is the exclusive global distributor of this system.

NeoBase™ Newborn Screening Kit: a non-derivatized kit that can be used to screen for 11 amino acids, 31 carnitines and succinylacetone, to detect metabolic disorders from a dried blood spot when using a tandem mass spectrometer. The kit provides the ability to screen for more than 30 metabolic disorders from a single sample as well as customize the screening to disorders most likely in a given population.

GSP® Neonatal G6PD kit: a newly launched, fully automated G6PD assay that completes PerkinElmer's GSP test menu, comprised of 9 neonatal screening assays. Its high throughput GSP instrument measures newborn screening samples with superior accuracy, safety and efficiency providing a flexible workflow for any newborn screening laboratory.

Maternal Fetal Health solutions: instruments, software and serum-based or dried blood spot-based assays for 1st and 2nd trimester aneuploidy screening. These offerings include:
PlGF assay and risk calculation software: intended for 1st trimester prediction of pre-eclampsia that can also be used for 1st trimester Down syndrome screening

Prenatal BoBs® Kits: a bead-based multiplex assay designed to detect aneuploidies of chromosomes 13, 18, 21, X and Y, as well as copy number changes in 9 common microdeletion syndrome regions.
chemagic Prepito®-D instrument: an innovative compact bench top solution for DNA/RNA isolation which represents the top quality sample preparation system now available as a compact CE IVD marked bench top instrument. The chemagic Prepito-D instrument utilizes many years of experience in automated, magnetic bead based nucleic acid isolation, delivering high yield and purity DNA/RNA that are integral to the success of downstream applications.
MORE: PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2.2 billion in 2013, has about 7,700 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at

Media Contact:
Leanne High
+1- 919-863-4375

Related Links

IR Contact
(781) 663 - 6900
940 Winter Street
Waltham, MA 02451
United States

Transfer Agent

Mailing addresses
Correspondence should be mailed to:
P.O. Box 505000
Louisville, KY 40233

Overnight correspondence should be sent to:
462 South 4th Street, Suite 1600
Louisville, KY 40202

Shareholder website
Shareholder online inquiries